Author + information
- I.H. Hashmi,
- Salim Hammad,
- Rajnikanth Rajagopal,
- Jurek Wojciuk,
- Shaun Rogers,
- Joanne Finnie,
- Ranjit More,
- Augustine Tang,
- Franco Sogliani and
- David Roberts
A new concept of risk stratification for patients with aortic stenosis, based upon age combined with a fixed number of predefined risk factors, was proposed during the design of SURTAVI trial. The purpose of this study was to compare the SURTAVI model with surgical risk scores i.e. logistic EuroSCORE (LES), EuroSCORE II (ES II) and STS score in patients selected by the “Heart Team” for TAVI after formal surgical turn down.
Eighty eight consecutive patients underwent TAVI via trans–femoral, trans–apical and other approaches. LES, ES II and STS score were calculated retrospectively. Patients were classified into low (≥70yrs and <2 risk factors, ≥75yrs and no risk factor), intermediate (≥70yrs and 2–3 risk factors, ≥75yrs and 1–2 risk factors, ≥80yrs and ≤1 risk factor) and high risk (≥70yrs and >3 risk factors, ≥75yrs and >2 risk factors, ≥80yrs and >1 risk factor) groups according to SURTAVI model and surgical risk scores (LES <10, 10 – 20, >20%, ES II <4, 4 −10, >10% and STS <4, 4 −10, >10% respectively) and actual 30–day and 1–year mortality was compared.
are summarised in the table below.
SURTAVI model was no better than other risk scores in predicting mortality, both at 30 days and 1 year, in patients undergoing TAVI after formal surgical turn down. This highlights deficiencies of the proposed SURTAVI risk model and thus emphasises on the role of a multidisciplinary “Heart Team” in risk assessment.
|30- day mortality|
|p – Value||0.562||0.875||1.0||0.376|
|p - Value||0.943||0.502||0.203||0.254|
Poster Sessions, Expo North
Saturday, March 09, 2013, 3:45 p.m.–4:30 p.m.
Session Title: Valvular Heart Disease: Clinical III – Aortic Valve Stenosis
Abstract Category: 31. Valvular Heart Disease: Clinical
Presentation Number: 1155–77
- 2013 American College of Cardiology Foundation